Concepts (196)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sleep Apnea, Obstructive | 14 | 2017 | 234 | 1.430 |
Why?
|
| Palatine Tonsil | 8 | 2010 | 36 | 0.990 |
Why?
|
| Adenoids | 6 | 2010 | 12 | 0.860 |
Why?
|
| Hypoxia | 8 | 2012 | 259 | 0.810 |
Why?
|
| Sleep Apnea Syndromes | 3 | 2012 | 83 | 0.500 |
Why?
|
| Polysomnography | 8 | 2011 | 155 | 0.490 |
Why?
|
| Adenoidectomy | 5 | 2011 | 84 | 0.390 |
Why?
|
| Snoring | 5 | 2017 | 18 | 0.380 |
Why?
|
| Tonsillectomy | 5 | 2011 | 109 | 0.370 |
Why?
|
| Erythropoietin | 1 | 2012 | 109 | 0.360 |
Why?
|
| Cognition Disorders | 3 | 2012 | 571 | 0.360 |
Why?
|
| Leukotriene Antagonists | 1 | 2008 | 18 | 0.300 |
Why?
|
| Vasculitis | 1 | 2007 | 50 | 0.270 |
Why?
|
| Posture | 1 | 2007 | 144 | 0.250 |
Why?
|
| Disease Models, Animal | 5 | 2012 | 4694 | 0.250 |
Why?
|
| Endothelium, Vascular | 1 | 2007 | 492 | 0.220 |
Why?
|
| Maze Learning | 4 | 2012 | 104 | 0.200 |
Why?
|
| Narcolepsy | 1 | 2022 | 6 | 0.200 |
Why?
|
| NADPH Oxidases | 3 | 2012 | 111 | 0.190 |
Why?
|
| Disorders of Excessive Somnolence | 1 | 2022 | 43 | 0.180 |
Why?
|
| Obesity | 3 | 2011 | 2396 | 0.170 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2022 | 189 | 0.170 |
Why?
|
| Embryonic Stem Cells | 2 | 2011 | 173 | 0.160 |
Why?
|
| Child, Preschool | 14 | 2017 | 14718 | 0.150 |
Why?
|
| Bone Marrow Cells | 2 | 2011 | 263 | 0.150 |
Why?
|
| Gene Regulatory Networks | 3 | 2011 | 383 | 0.150 |
Why?
|
| Hypertrophy | 5 | 2010 | 101 | 0.150 |
Why?
|
| Child | 18 | 2022 | 25758 | 0.150 |
Why?
|
| Cells, Cultured | 4 | 2012 | 3061 | 0.140 |
Why?
|
| Tick Paralysis | 1 | 2017 | 1 | 0.140 |
Why?
|
| Tick-Borne Diseases | 1 | 2017 | 13 | 0.140 |
Why?
|
| Influenza Vaccines | 1 | 2022 | 498 | 0.140 |
Why?
|
| Lipid Peroxidation | 3 | 2012 | 93 | 0.130 |
Why?
|
| DiGeorge Syndrome | 1 | 2017 | 82 | 0.130 |
Why?
|
| Severity of Illness Index | 6 | 2017 | 3083 | 0.130 |
Why?
|
| Muscle Weakness | 1 | 2017 | 93 | 0.130 |
Why?
|
| Oximetry | 1 | 2017 | 178 | 0.130 |
Why?
|
| Sleep | 3 | 2022 | 373 | 0.130 |
Why?
|
| Male | 24 | 2022 | 64918 | 0.120 |
Why?
|
| Influenza, Human | 1 | 2022 | 700 | 0.120 |
Why?
|
| Deoxyguanosine | 2 | 2012 | 13 | 0.120 |
Why?
|
| Swimming | 2 | 2012 | 29 | 0.120 |
Why?
|
| Epilepsy | 2 | 2017 | 891 | 0.120 |
Why?
|
| Gene Expression Regulation | 4 | 2012 | 2444 | 0.120 |
Why?
|
| Analysis of Variance | 3 | 2012 | 1008 | 0.110 |
Why?
|
| Cell Proliferation | 4 | 2009 | 2512 | 0.110 |
Why?
|
| Case-Control Studies | 4 | 2010 | 3418 | 0.110 |
Why?
|
| Cell Culture Techniques | 3 | 2009 | 288 | 0.100 |
Why?
|
| Tonsillitis | 2 | 2010 | 13 | 0.100 |
Why?
|
| Women | 1 | 2012 | 18 | 0.100 |
Why?
|
| Escape Reaction | 1 | 2012 | 14 | 0.100 |
Why?
|
| Injections, Intraperitoneal | 1 | 2012 | 69 | 0.100 |
Why?
|
| Malondialdehyde | 1 | 2012 | 52 | 0.100 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2012 | 31 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 5 | 2012 | 4764 | 0.090 |
Why?
|
| Evoked Potentials | 2 | 2009 | 121 | 0.090 |
Why?
|
| Cell Shape | 1 | 2011 | 70 | 0.090 |
Why?
|
| Female | 18 | 2022 | 70680 | 0.090 |
Why?
|
| Actigraphy | 1 | 2011 | 48 | 0.090 |
Why?
|
| Humans | 22 | 2022 | 132105 | 0.080 |
Why?
|
| Pluripotent Stem Cells | 1 | 2011 | 79 | 0.080 |
Why?
|
| Embryo, Mammalian | 1 | 2012 | 460 | 0.080 |
Why?
|
| Bronchiolitis, Viral | 1 | 2009 | 29 | 0.080 |
Why?
|
| Circadian Rhythm | 1 | 2012 | 316 | 0.080 |
Why?
|
| Time Factors | 4 | 2012 | 6445 | 0.080 |
Why?
|
| SRS-A | 1 | 2008 | 1 | 0.080 |
Why?
|
| Leukotriene D4 | 1 | 2008 | 6 | 0.080 |
Why?
|
| Gene Expression Profiling | 3 | 2011 | 1879 | 0.080 |
Why?
|
| Adaptation, Psychological | 1 | 2012 | 455 | 0.080 |
Why?
|
| Cytokines | 3 | 2009 | 1367 | 0.080 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2010 | 124 | 0.080 |
Why?
|
| Cerebral Cortex | 1 | 2012 | 484 | 0.080 |
Why?
|
| Memory | 1 | 2012 | 355 | 0.080 |
Why?
|
| Membrane Glycoproteins | 1 | 2011 | 421 | 0.070 |
Why?
|
| Sulfides | 1 | 2008 | 25 | 0.070 |
Why?
|
| Androstadienes | 1 | 2008 | 52 | 0.070 |
Why?
|
| Acetates | 1 | 2008 | 80 | 0.070 |
Why?
|
| RNA Polymerase II | 1 | 2008 | 87 | 0.070 |
Why?
|
| Cyclopropanes | 1 | 2008 | 71 | 0.070 |
Why?
|
| Catechin | 1 | 2008 | 13 | 0.070 |
Why?
|
| Hydroxyurea | 1 | 2008 | 85 | 0.070 |
Why?
|
| Interleukins | 1 | 2008 | 129 | 0.070 |
Why?
|
| Apoptosis | 3 | 2010 | 1904 | 0.070 |
Why?
|
| Quinolines | 1 | 2008 | 122 | 0.070 |
Why?
|
| Hyperemia | 1 | 2007 | 35 | 0.070 |
Why?
|
| Middle Ear Ventilation | 1 | 2007 | 35 | 0.070 |
Why?
|
| CD40 Ligand | 1 | 2007 | 64 | 0.070 |
Why?
|
| Tyrosine | 1 | 2007 | 148 | 0.070 |
Why?
|
| Otolaryngology | 1 | 2009 | 108 | 0.070 |
Why?
|
| Stress, Psychological | 1 | 2012 | 578 | 0.070 |
Why?
|
| Attention | 1 | 2009 | 200 | 0.070 |
Why?
|
| Dexamethasone | 1 | 2008 | 274 | 0.070 |
Why?
|
| Otitis Media | 1 | 2007 | 90 | 0.070 |
Why?
|
| Enzyme Inhibitors | 1 | 2010 | 589 | 0.060 |
Why?
|
| Prefrontal Cortex | 1 | 2008 | 218 | 0.060 |
Why?
|
| Plant Extracts | 1 | 2008 | 135 | 0.060 |
Why?
|
| Adolescent | 5 | 2017 | 20532 | 0.060 |
Why?
|
| Hippocampus | 2 | 2008 | 819 | 0.060 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2008 | 305 | 0.060 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2009 | 236 | 0.060 |
Why?
|
| Glucocorticoids | 1 | 2008 | 387 | 0.060 |
Why?
|
| Body Mass Index | 2 | 2009 | 1700 | 0.060 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2009 | 377 | 0.060 |
Why?
|
| Arginine | 1 | 2007 | 341 | 0.060 |
Why?
|
| Referral and Consultation | 1 | 2009 | 569 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 1672 | 0.060 |
Why?
|
| Immunohistochemistry | 1 | 2008 | 1723 | 0.060 |
Why?
|
| RNA, Messenger | 1 | 2011 | 2679 | 0.060 |
Why?
|
| Sleep Wake Disorders | 1 | 2007 | 197 | 0.060 |
Why?
|
| Nitric Oxide | 1 | 2007 | 470 | 0.060 |
Why?
|
| Infant | 3 | 2009 | 13039 | 0.050 |
Why?
|
| Mice | 5 | 2012 | 18566 | 0.050 |
Why?
|
| Asthma | 1 | 2011 | 771 | 0.050 |
Why?
|
| Body Weight | 1 | 2007 | 993 | 0.050 |
Why?
|
| Primary Health Care | 1 | 2009 | 801 | 0.050 |
Why?
|
| Animals | 7 | 2012 | 34953 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2009 | 5150 | 0.050 |
Why?
|
| Cognition | 1 | 2008 | 810 | 0.050 |
Why?
|
| Risk Factors | 4 | 2009 | 10902 | 0.050 |
Why?
|
| Age Factors | 1 | 2009 | 2922 | 0.050 |
Why?
|
| Neurons | 1 | 2012 | 2016 | 0.050 |
Why?
|
| Inflammation | 1 | 2009 | 1522 | 0.050 |
Why?
|
| Lung | 1 | 2008 | 1556 | 0.040 |
Why?
|
| Chemokines | 2 | 2011 | 130 | 0.040 |
Why?
|
| Comorbidity | 3 | 2011 | 1606 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2012 | 2683 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2022 | 6530 | 0.040 |
Why?
|
| Microarray Analysis | 2 | 2010 | 237 | 0.040 |
Why?
|
| Kentucky | 2 | 2007 | 28 | 0.030 |
Why?
|
| Rats | 3 | 2008 | 3612 | 0.030 |
Why?
|
| Flow Cytometry | 2 | 2010 | 806 | 0.030 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2017 | 46 | 0.030 |
Why?
|
| Electromyography | 1 | 2017 | 140 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2009 | 828 | 0.030 |
Why?
|
| Vaccination | 1 | 2022 | 1017 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2017 | 3854 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2008 | 1225 | 0.030 |
Why?
|
| Incidence | 1 | 2022 | 3365 | 0.030 |
Why?
|
| Recurrence | 2 | 2009 | 1454 | 0.030 |
Why?
|
| Neuropsychological Tests | 2 | 2009 | 989 | 0.030 |
Why?
|
| Surveys and Questionnaires | 2 | 2017 | 3982 | 0.030 |
Why?
|
| Electroencephalography | 2 | 2009 | 908 | 0.020 |
Why?
|
| NADPH Oxidase 2 | 1 | 2011 | 38 | 0.020 |
Why?
|
| Leukemia Inhibitory Factor | 1 | 2010 | 27 | 0.020 |
Why?
|
| Chemokine CXCL12 | 1 | 2010 | 36 | 0.020 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2010 | 37 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 3021 | 0.020 |
Why?
|
| Algorithms | 1 | 2017 | 1724 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2010 | 156 | 0.020 |
Why?
|
| Wakefulness | 1 | 2011 | 105 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2010 | 65 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2010 | 140 | 0.020 |
Why?
|
| Phenotype | 2 | 2011 | 4541 | 0.020 |
Why?
|
| Self Report | 1 | 2012 | 553 | 0.020 |
Why?
|
| Retinol-Binding Proteins, Cellular | 1 | 2008 | 2 | 0.020 |
Why?
|
| Fluticasone | 1 | 2008 | 15 | 0.020 |
Why?
|
| PC12 Cells | 1 | 2008 | 28 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2022 | 17374 | 0.020 |
Why?
|
| Cullin Proteins | 1 | 2008 | 14 | 0.020 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2008 | 37 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2007 | 3738 | 0.020 |
Why?
|
| Drug Delivery Systems | 1 | 2010 | 226 | 0.020 |
Why?
|
| Adult | 3 | 2017 | 31557 | 0.020 |
Why?
|
| Tea | 1 | 2008 | 18 | 0.020 |
Why?
|
| Serine | 1 | 2008 | 166 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2011 | 1046 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2008 | 439 | 0.020 |
Why?
|
| Age Distribution | 1 | 2009 | 433 | 0.020 |
Why?
|
| Causality | 1 | 2007 | 90 | 0.020 |
Why?
|
| Sleep Stages | 1 | 2007 | 34 | 0.020 |
Why?
|
| Cell Movement | 1 | 2011 | 891 | 0.020 |
Why?
|
| Child Behavior Disorders | 1 | 2007 | 70 | 0.020 |
Why?
|
| Temporal Lobe | 1 | 2007 | 118 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2009 | 579 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 2009 | 543 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2010 | 554 | 0.020 |
Why?
|
| RNA | 1 | 2010 | 549 | 0.020 |
Why?
|
| Reference Values | 1 | 2007 | 704 | 0.020 |
Why?
|
| Computational Biology | 1 | 2011 | 873 | 0.020 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2009 | 855 | 0.010 |
Why?
|
| Brain | 1 | 2017 | 3201 | 0.010 |
Why?
|
| Estrogen Receptor alpha | 1 | 2008 | 439 | 0.010 |
Why?
|
| Genotype | 1 | 2011 | 2706 | 0.010 |
Why?
|
| Disease Progression | 1 | 2011 | 2227 | 0.010 |
Why?
|
| Prevalence | 1 | 2011 | 2659 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2008 | 1050 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2008 | 799 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2011 | 3873 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2009 | 1597 | 0.010 |
Why?
|
| Parents | 1 | 2009 | 1080 | 0.010 |
Why?
|
| Biomarkers | 1 | 2010 | 3380 | 0.010 |
Why?
|
| Quality of Life | 1 | 2011 | 2152 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2009 | 1758 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2011 | 13017 | 0.010 |
Why?
|
| Aged | 1 | 2012 | 21413 | 0.010 |
Why?
|
| Middle Aged | 1 | 2012 | 28936 | 0.010 |
Why?
|